ASCO 2025 – Highlights & RIGHT Choice Update with Dr. Nagi El Saghir

Dr. Nagi El Saghir shares a summary of ASCO 2025, including key takeaways from his poster on the RIGHT Choice subgroup analysis, and highlights major updates from INAVO120, SERENA-6, VERITAC-2, and DESTINY-Breast09 trials.